Insider Transactions in Q1 2024 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,448
-4.72%
|
$94,120
$65.82 P/Share
|
|
Feb 17
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.54%
|
-
|
|
Feb 16
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-1.71%
|
$35,100
$65.82 P/Share
|
|
Feb 16
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,838
+5.49%
|
-
|
|
Feb 16
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-0.95%
|
$117,390
$65.82 P/Share
|
|
Feb 16
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,960
+2.03%
|
-
|
|
Feb 16
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,882
-0.7%
|
$122,330
$65.82 P/Share
|
|
Feb 16
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,243
+1.55%
|
-
|
|
Feb 16
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,130
-3.5%
|
$73,450
$65.82 P/Share
|
|
Feb 16
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,546
+7.3%
|
-
|
|
Feb 16
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,214
-0.43%
|
$468,910
$65.82 P/Share
|
|
Feb 16
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,265
+0.97%
|
-
|
|
Feb 16
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-1.49%
|
$59,150
$65.82 P/Share
|
|
Feb 16
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,051
+3.26%
|
-
|
|
Feb 16
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,355
-1.79%
|
$88,075
$65.82 P/Share
|
|
Feb 16
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+3.78%
|
-
|
|
Feb 16
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-1.14%
|
$27,755
$65.82 P/Share
|
|
Feb 16
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+2.58%
|
-
|
|
Feb 16
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-1.17%
|
$37,765
$65.82 P/Share
|
|
Feb 16
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,273
+2.49%
|
-
|
|
Feb 16
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-4.45%
|
$85,215
$65.82 P/Share
|
|
Feb 16
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,263
+7.13%
|
-
|
|
Feb 14
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,935
-0.73%
|
$125,775
$65.95 P/Share
|
|
Feb 14
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,362
+1.61%
|
-
|
|
Feb 14
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
629
-2.07%
|
$40,885
$65.95 P/Share
|
|
Feb 14
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,850
+5.73%
|
-
|
|
Feb 14
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,408
-4.52%
|
$91,520
$65.95 P/Share
|
|
Feb 14
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
3,172
+9.23%
|
-
|
|
Feb 14
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-1.05%
|
$129,350
$65.95 P/Share
|
|
Feb 14
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,362
+2.26%
|
-
|
|
Feb 14
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-1.57%
|
$61,035
$65.95 P/Share
|
|
Feb 14
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+3.42%
|
-
|
|
Feb 14
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,328
-0.44%
|
$476,320
$65.95 P/Share
|
|
Feb 14
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,523
+0.99%
|
-
|
|
Feb 14
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,266
-1.71%
|
$82,290
$65.95 P/Share
|
|
Feb 14
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,776
+3.62%
|
-
|
|
Feb 14
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-1.32%
|
$31,720
$65.95 P/Share
|
|
Feb 14
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,057
+2.78%
|
-
|
|
Feb 14
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
965
-1.95%
|
$62,725
$65.95 P/Share
|
|
Feb 14
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+4.1%
|
-
|
|
Feb 14
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,378
-4.82%
|
$89,570
$65.95 P/Share
|
|
Feb 14
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,379
+7.69%
|
-
|
|
Feb 13
2024
|
Edward J Ludwig Director |
SELL
Open market or private sale
|
Direct |
7,000
-14.47%
|
$455,000
$65.03 P/Share
|
|
Feb 13
2024
|
Edward J Ludwig Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+12.64%
|
$119,000
$17.37 P/Share
|
|
Feb 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
550
+10.1%
|
-
|
|
Feb 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
6,000
-3.15%
|
-
|
|
Feb 06
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,262
-5.84%
|
-
|
|
Feb 06
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
36,666
+11.64%
|
-
|
|
Feb 06
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,722
-25.77%
|
-
|
|
Feb 06
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Grant, award, or other acquisition
|
Direct |
22,666
+37.53%
|
-
|